Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Cellebrite DI (CLBT) Equity Ratio: 2020-2025

Historic Equity Ratio for Cellebrite DI (CLBT) over the last 4 years, with Sep 2025 value amounting to 1.00.

  • Cellebrite DI's Equity Ratio changed negligibly% to 1.00 in Q3 2025 from the same period last year, while for Sep 2025 it was 1.00, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of 0.49 for FY2024, which is 657.90% up from last year.
  • Latest data reveals that Cellebrite DI reported Equity Ratio of 1.00 as of Q3 2025, which was down 0.00% from 1.00 recorded in Q2 2025.
  • Cellebrite DI's 5-year Equity Ratio high stood at 373.05 for Q2 2024, and its period low was -0.41 during Q3 2021.
  • Over the past 3 years, Cellebrite DI's median Equity Ratio value was 1.00 (recorded in 2025), while the average stood at 34.60.
  • Its Equity Ratio has fluctuated over the past 5 years, first crashed by 223.28% in 2021, then surged by 158,237,407.03% in 2024.
  • Quarterly analysis of 5 years shows Cellebrite DI's Equity Ratio stood at -0.22 in 2021, then surged by 184.85% to 0.18 in 2022, then tumbled by 64.95% to 0.06 in 2023, then soared by 657.90% to 0.49 in 2024, then remained steady at 1.00 in 2025.
  • Its Equity Ratio was 1.00 in Q3 2025, compared to 1.00 in Q2 2025 and 1.00 in Q1 2025.